Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Frye

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Neuro-Oncology Advances|July 10, 2020
MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironmentYu-Ting Su, Madison Butler, Meili Zhang, et al.
Plos One|July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemiaMatthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Journal of Medicinal Chemistry|November 14, 2013
Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosisWeihe Zhang, Andrew L McIver, Michael A Stashko, et al.
Journal of Medicinal Chemistry|July 10, 2010
Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolinesFeng Liu, Xin Chen, Abdellah Allali-Hassani, et al.
Journal of the American Chemical Society|September 10, 2019
Data-Driven Construction of Antitumor Agents with Controlled PolypharmacologyChenxiao Da, Dehui Zhang, Michael Stashko, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Cell Chemical Biology|August 20, 2019
Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7Kelsey N Lamb, Daniel Bsteh, Sarah N Dishman, et al.
Molecular Cancer Therapeutics|August 11, 2018
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting AgentsNellie K McDaniel, Christopher T Cummings, Mari Iida, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
Chemistry & Biology|September 15, 2015
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityBret D Wallace, Adam B Roberts, Rebecca M Pollet, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Neuro-Oncology Advances|July 10, 2020
MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironmentYu-Ting Su, Madison Butler, Meili Zhang, et al.
Plos One|July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemiaMatthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Journal of Medicinal Chemistry|November 14, 2013
Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosisWeihe Zhang, Andrew L McIver, Michael A Stashko, et al.
Journal of Medicinal Chemistry|July 10, 2010
Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolinesFeng Liu, Xin Chen, Abdellah Allali-Hassani, et al.
Journal of the American Chemical Society|September 10, 2019
Data-Driven Construction of Antitumor Agents with Controlled PolypharmacologyChenxiao Da, Dehui Zhang, Michael Stashko, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Cell Chemical Biology|August 20, 2019
Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7Kelsey N Lamb, Daniel Bsteh, Sarah N Dishman, et al.
Molecular Cancer Therapeutics|August 11, 2018
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting AgentsNellie K McDaniel, Christopher T Cummings, Mari Iida, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
Chemistry & Biology|September 15, 2015
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityBret D Wallace, Adam B Roberts, Rebecca M Pollet, et al.
Pageof 13